共 49 条
- [42] Depression and active disease are the major risk factors for fatigue and sleep disturbance in inflammatory bowel disease with consequent poor quality of life: Analysis of the interplay between psychosocial factors from the developing world Indian Journal of Gastroenterology, 2024, 43 : 226 - 236
- [43] Depression and active disease are the major risk factors for fatigue and sleep disturbance in inflammatory bowel disease with consequent poor quality of life: Analysis of the interplay between psychosocial factors from the developing world INDIAN JOURNAL OF GASTROENTEROLOGY, 2024, 43 (01) : 226 - 236
- [44] Review on the Safety and Efficacy of Brolucizumab for Neovascular Age-Related Macular Degeneration Erratum Major Studies and Real-World Data (vol 12, pg 168, 2023) ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2023, 12 (04): : 422 - 422
- [48] Growth of Artificial Intelligence in Pharma Manufacturing Lonza describes how artificial intelligence, machine learning, and big data are improving safety, quality, and sustainability - All while lowering costs Genetic Engineering and Biotechnology News, 2022, 43 (01): : 34 - 36
- [49] Cyclobenzaprine (CBP) and Its Major Metabolite Norcyclobenzaprine (nCBP) Are Potent Antagonists of Human Serotonin Receptor 2a (5HT2a), Histamine Receptor H-1 and a-Adrenergic Receptors: Mechanistic and Safety Implications for Treating Fibromyalgia Syndrome by Improving Sleep Quality. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S416 - S416